Takeda (TAK) director Bruce Broussard receives 3,800 ADS RSUs and 1,319 tax awards

Rhea-AI Filing Summary

Takeda Pharmaceutical Co. Ltd. director Bruce D. Broussard received equity-based compensation rather than buying shares on the market. He was granted 3,800 American Depositary Shares (ADS) on a cost-free basis, increasing his direct holdings to 4,595 ADS after the award.

The grant represents restricted stock units (RSUs), each linked to one Ordinary Share that will convert into an equivalent number of ADS when the award vests on June 1, 2029. These RSUs are contingent and only settle if vesting conditions are met.

Broussard was also granted 1,319 units of a Tax Obligation Award, economically equivalent to one Ordinary Share each. Upon vesting on June 1, 2029, these are designed to pay cash at the then-current market price primarily to cover related tax obligations, rather than delivering additional shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider BROUSSARD BRUCE D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Tax Obligation Award	1,319	$0.00	--
Grant/Award	American Depositary Shares	3,800	$0.00	--

Holdings After Transaction: Tax Obligation Award — 1,319 shares (Direct, null); American Depositary Shares — 4,595 shares (Direct, null)

Footnotes (1)

1. Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Key Figures

RSU ADS grant: 3,800 shares Holdings after grant: 4,595 ADS Tax Obligation Award units: 1,319 units +2 more

5 metrics

RSU ADS grant 3,800 shares American Depositary Shares granted as RSUs on July 1, 2026

Holdings after grant 4,595 ADS Direct American Depositary Share holdings after the award

Tax Obligation Award units 1,319 units Derivative units economically equivalent to Ordinary Shares

RSU vesting date June 1, 2029 RSUs convert into Ordinary Shares and then ADS at vesting

Tax Award vesting date June 1, 2029 Tax Obligation Award settles in cash at then-current market price

Key Terms

restricted stock units (RSU), American Depositary Shares, Ordinary Share, Tax Obligation Award

4 terms

restricted stock units (RSU) financial

"Represents an award of restricted stock units (RSU). Each RSU represents a contingent right"

American Depositary Shares financial

"which will be converted into an equivalent number of American Depositary Shares following vest."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Ordinary Share financial

"Each RSU represents a contingent right to receive one Ordinary Share"

An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

Tax Obligation Award financial

"Each Tax Obligation Award is the economic equivalent of one Ordinary Share"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 06:12 PM Accepted by SEC EDGAR 07/06/2026 - 06:12 PM Learn about SEC filing dates

FAQ

What did Bruce D. Broussard acquire in this Takeda (TAK) Form 4 filing?

Bruce D. Broussard received 3,800 American Depositary Shares as an equity award, not a market purchase. These were granted at no cost as restricted stock units that convert into ADS after vesting, reflecting standard director compensation rather than active buying.

How many Takeda (TAK) shares does Bruce D. Broussard hold after this award?

After the award, Bruce D. Broussard directly holds 4,595 American Depositary Shares. This total includes the impact of the 3,800-share grant reported in the filing and reflects his updated direct ownership position in Takeda following the compensation grant.

When do Bruce D. Broussard’s Takeda (TAK) RSUs vest?

The restricted stock units granted to Bruce D. Broussard vest on June 1, 2029. At vesting, each RSU converts into one Ordinary Share that is then delivered as an equivalent number of American Depositary Shares, assuming all vesting conditions are satisfied.

What is the Tax Obligation Award reported for Bruce D. Broussard at Takeda (TAK)?

The Tax Obligation Award consists of 1,319 units, each economically equal to one Ordinary Share. When these units vest, they convert into a cash payment at the then-current market price, primarily to cover tax obligations associated with the equity award.

Did Bruce D. Broussard buy or sell Takeda (TAK) shares on the open market?

No open-market trades occurred in this filing. The transactions reflect grant or award acquisitions at a price of $0.00 per share, indicating compensation-related RSUs and Tax Obligation Awards rather than discretionary buying or selling on public markets.

How many derivative units tied to Takeda (TAK) shares did Broussard receive?

Bruce D. Broussard received 1,319 derivative units classified as a Tax Obligation Award. Each unit is economically equivalent to one Ordinary Share and will settle in cash upon vesting, primarily to cover taxes instead of adding more Takeda shares to his holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROUSSARD BRUCE D

(Last) (First) (Middle)

C/O HP INC.

1501 PAGE MILL ROAD

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		3,800	A	$0	4,595	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Tax Obligation Award	(2)	07/01/2026		A		1,319		06/01/2029	06/01/2029	Ordinary Shares	1,319	$0	1,319	D

Explanation of Responses:

1. Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.

2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Remarks:

	/s/ Samuel Ntonme, by power of attorney, for Bruce D Broussard	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)